JP2022529466A5 - - Google Patents
Info
- Publication number
- JP2022529466A5 JP2022529466A5 JP2021561813A JP2021561813A JP2022529466A5 JP 2022529466 A5 JP2022529466 A5 JP 2022529466A5 JP 2021561813 A JP2021561813 A JP 2021561813A JP 2021561813 A JP2021561813 A JP 2021561813A JP 2022529466 A5 JP2022529466 A5 JP 2022529466A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- unsubstituted
- alkyl
- compound according
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962835301P | 2019-04-17 | 2019-04-17 | |
| US62/835,301 | 2019-04-17 | ||
| PCT/US2020/028349 WO2020214728A1 (en) | 2019-04-17 | 2020-04-15 | Bicyclic and tricyclic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022529466A JP2022529466A (ja) | 2022-06-22 |
| JP2022529466A5 true JP2022529466A5 (https=) | 2023-04-24 |
| JP7381602B2 JP7381602B2 (ja) | 2023-11-15 |
Family
ID=72838352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021561813A Active JP7381602B2 (ja) | 2019-04-17 | 2020-04-15 | 二環式及び三環式化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11591341B2 (https=) |
| EP (1) | EP3956331A4 (https=) |
| JP (1) | JP7381602B2 (https=) |
| KR (1) | KR102641566B1 (https=) |
| CN (1) | CN113939513A (https=) |
| AU (1) | AU2020260105A1 (https=) |
| CA (1) | CA3136603A1 (https=) |
| TW (1) | TWI819213B (https=) |
| WO (1) | WO2020214728A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4229062A4 (en) * | 2020-10-15 | 2024-10-30 | Aligos Therapeutics, Inc. | Bicyclic compounds |
| CN114478536B (zh) * | 2020-10-28 | 2024-12-13 | 上海森辉医药有限公司 | 四氢吡嗪稠环衍生物的制备方法 |
| EP4399217A2 (en) | 2021-09-08 | 2024-07-17 | Aligos Therapeutics, Inc. | Modified short interfering nucleic acid (sina) molecules and uses thereof |
| EP4511374A4 (en) | 2022-04-20 | 2026-04-08 | Aligos Therapeutics Inc | BICYCLE COMPOUNDS |
| EP4707279A1 (en) * | 2023-05-02 | 2026-03-11 | Albius Sciences Beta Pte. Ltd. | Substituted tricyclic heterocyclic compound as pharmaceutical for treatment or prevention of covid-19 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2051966A2 (en) * | 2006-08-09 | 2009-04-29 | Pfizer Products Inc. | Heterocycles useful as inhibitors of carbonic anhydrase |
| MA41338B1 (fr) | 2015-01-16 | 2019-07-31 | Hoffmann La Roche | Composés de pyrazine pour le traitement de maladies infectieuses |
| US20160304496A1 (en) * | 2015-04-17 | 2016-10-20 | Abbvie Inc. | Indazolones as modulators of tnf signaling |
| US10179131B2 (en) * | 2015-07-13 | 2019-01-15 | Enanta Pharmaceuticals, Inc. | Hepatitis B antiviral agents |
| CN110066278B (zh) * | 2017-06-01 | 2021-06-08 | 广东东阳光药业有限公司 | 稠合三环类化合物及其在药物中的应用 |
| PE20211783A1 (es) | 2018-11-08 | 2021-09-08 | Aligos Therapeutics Inc | Polimeros oligonucleotidos que inhiben el transporte de antigenos y metodos |
| EP4229062A4 (en) | 2020-10-15 | 2024-10-30 | Aligos Therapeutics, Inc. | Bicyclic compounds |
-
2020
- 2020-04-15 AU AU2020260105A patent/AU2020260105A1/en not_active Abandoned
- 2020-04-15 CA CA3136603A patent/CA3136603A1/en active Pending
- 2020-04-15 KR KR1020217037462A patent/KR102641566B1/ko active Active
- 2020-04-15 WO PCT/US2020/028349 patent/WO2020214728A1/en not_active Ceased
- 2020-04-15 EP EP20791559.6A patent/EP3956331A4/en not_active Withdrawn
- 2020-04-15 CN CN202080040122.7A patent/CN113939513A/zh active Pending
- 2020-04-15 JP JP2021561813A patent/JP7381602B2/ja active Active
- 2020-04-15 US US16/849,851 patent/US11591341B2/en active Active
- 2020-04-16 TW TW109112853A patent/TWI819213B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022529466A5 (https=) | ||
| JP2021534124A5 (https=) | ||
| JP6524081B2 (ja) | ジヒドロピリミジン化合物及び医薬におけるその適用 | |
| ES2831333T3 (es) | Moduladores de la proteína nuclear de la hepatitis B | |
| JP2015526448A5 (https=) | ||
| ES2565436T3 (es) | Derivados de la piridina pirazolo como inhibidores de la NADPH oxidasa | |
| ES2773138T3 (es) | Derivados de 3-(2-aminopirimidin-4-il)-5-(3-hidroxipropinil)-1H-pirrolo[2,3-c]piridina como inhibidores de NIK para el tratamiento del cáncer | |
| JP2022501430A5 (https=) | ||
| JP2014520822A5 (https=) | ||
| JP2010514768A5 (https=) | ||
| RU2015110082A (ru) | Соединения дигидропиримидина и их применение в фармацевтических препаратах | |
| JP2022534501A5 (https=) | ||
| JP2018533611A5 (https=) | ||
| JP2022522312A5 (https=) | ||
| CN108430993A (zh) | Tank-结合激酶抑制剂化合物 | |
| WO2018013597A4 (en) | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors | |
| JP2022522486A5 (https=) | ||
| JP2023520916A5 (https=) | ||
| BR112016018633B1 (pt) | Pirazolopirimidina-5,7-diaminas como inibidores de cdk, seus usos, composição farmacêutica e seu método de preparação, e método in vitro para inibir a função de quinase dependente de ciclina em uma célula | |
| RU2009105826A (ru) | 2,4-ди(ариламино)питимидин-5-карбоксамидные соединения в качестве ингибиторов jak-киназ | |
| RU2016138735A (ru) | Соединения дигидропиримидина и их применение в фармацевтических препаратах | |
| RU2017145650A (ru) | Ингибиторы тирозинкиназы брутона | |
| RU2018127728A (ru) | Слитые трициклические гетероциклические соединения в качестве ингибиторов интегразы вич | |
| KR20230057419A (ko) | 인지질 화합물 및 이의 용도 | |
| JPWO2021060453A5 (https=) |